Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-043070
Filing Date
2012-08-01
Accepted
2012-08-01 20:35:50
Documents
1
Period of Report
2012-07-30

Document Format Files

Seq Description Document Type Size
1 rrd352107.html 4  
1 rrd352107.xml 4 3836
  Complete submission text file 0001181431-12-043070.txt   5191
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INTARCIA THERAPEUTICS, INC. 2000 POWELL ST., SUITE 1640 EMERYVILLE CA 94608
Business Address
LANGECKER PETER (Reporting) CIK: 0001282829 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 121001469